01 / 12 / 2020

J2L Holding AB acquires Swereco AB

J2L has acquired all the shares in Swereco (former subsidiary of Karo Pharma AB) and thus became the owner of Swereco AB with subsidiaries.

Swereco AB is a medical technology company that provides products for rehabilitation under its own brand Swereco® as well as several licensed products in intensive care, diabetes treatment and surgery. Swereco delivers directly to hospitals and regions in Sweden and via distributors in the Nordics and some EU countries.

“We are convinced that under J2L’s ownership, Swereco will have the best conditions for continued development and growth both on the home and export markets in the coming years. We welcome J2L as owner of Swereco AB”, says incoming CEO Hadi Ghane.

For further information please contact:
Johan Lindh, Chairman of the Board, +4670 524 34 04, johan.lindh@j2l.se
Hadi Ghane, CEO, +46 733 762 764, hadi.ghane@swereco.com

Stockholm 1 Dec 2020

J2L Holding AB förvärvar Swereco AB